NCT01300663

Brief Summary

Post-surgery complications in women with vulvar neoplasms (vulvar intraepithelial neoplasia and vulvar cancer) are still high and an instrument assessing patients self-reported post-vulval surgery symptom experiences is missing. The study aims to develop and validate a postoperative instrument to assess symptom experiences in women with vulvar neoplasms. In this mixed-method project 20 patients were interviewed, a WOMAN-PRO instrument was developed and content validity was tested by 6 experts and 10 patients. The instrument's psychometric properties and the prevalence of symptoms will be examined in a cross-sectional study in the University Hospitals Munich, Freiburg, Berlin, Düsseldorf, Zurich, Basel, Berne, and the Cantonal Hospital St. Gallen (N=150). The goal of this project is that symptom assessment becomes a standard component of clinical practice (to promote the early detection and treatment of symptoms) and research.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2009

Typical duration for all trials

Geographic Reach
2 countries

8 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

February 22, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 23, 2011

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

February 23, 2011

Status Verified

February 1, 2011

Enrollment Period

2.9 years

First QC Date

February 22, 2011

Last Update Submit

February 22, 2011

Conditions

Study Arms (1)

post-surgery symptom experience

women with vulvar intraephitelial neoplasia or vulvar cancer

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

women with vulvar intraephitelial neoplasia or vulvar cancer following vulvar surgery

You may qualify if:

  • above 18 years old
  • able to read and write German
  • diagnosed with vulvar neoplasms
  • treated with vulval surgery during the prior six month

You may not qualify if:

  • cognitive impaired
  • concurrently under psychiatric treatment or terminally ill

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

University Hospital Berlin

Berlin, Germany

RECRUITING

University Hospital Dusseldorf

Düsseldorf, Germany

RECRUITING

University Hospital Freiburg

Freiburg im Breisgau, Germany

RECRUITING

University Hospital Munich

Munich, Germany

RECRUITING

University Hospital Basel

Basel, Switzerland

NOT YET RECRUITING

University Hospital Berne

Bern, Switzerland

RECRUITING

Cantonal Hospital St. Gallen

Sankt Gallen, Switzerland

RECRUITING

University Hospital Zurich

Zurich, Switzerland

RECRUITING

Related Publications (2)

  • Senn B, Mueller MD, Cignacco EL, Eicher M. Period prevalence and risk factors for postoperative short-term wound complications in vulvar cancer: a cross-sectional study. Int J Gynecol Cancer. 2010 May;20(4):646-54. doi: 10.1111/IGC.0b013e3181d92723.

  • Senn B, Eicher M, Mueller MD, Hornung R, Fink D, Baessler K, Hampl M, Denhaerynck K, Spirig R, Engberg S. A patient-reported outcome measure to identify occurrence and distress of post-surgery symptoms of WOMen with vulvAr Neoplasia (WOMAN-PRO) - a cross sectional study. Gynecol Oncol. 2013 Apr;129(1):234-40. doi: 10.1016/j.ygyno.2012.12.038. Epub 2013 Jan 3.

MeSH Terms

Conditions

Vulvar Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsVulvar DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Central Study Contacts

Rebecca Spirig, Prof. PhD, RN

CONTACT

Beate Senn, MSc, RN

CONTACT

Study Design

Study Type
observational
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 22, 2011

First Posted

February 23, 2011

Study Start

January 1, 2009

Primary Completion

December 1, 2011

Study Completion

December 1, 2011

Last Updated

February 23, 2011

Record last verified: 2011-02

Locations